missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Description
Immunogen sequence: YNFLPEFLVS TQKTYGADLA SVDFQHASED ARKTINQWVK GQTEGKIPEL LASGMVDNMT KLVLVN Highest antigen sequence identity to the following orthologs: Mouse - 88%, Rat - 89%.
Regulates the activity of the neutrophil proteases elastase, cathepsin G, proteinase-3, chymase, chymotrypsin, and kallikrein-3.
Spécification
Spécification
| Antígeno | SERPINB1 |
| Aplicaciones | Immunohistochemistry (Paraffin), Western Blot |
| Clasificación | Polyclonal |
| Concentración | 0.05 mg/mL |
| Conjugado | Unconjugated |
| Formulación | PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 |
| génica | SERPINB1 |
| N.º de referencia del gen | P30740 |
| Alias de gen | 1190005M04Rik; AI325983; Anti elastase; anti-elastase; EGK_14416; EI; EIA; ELANH2; epididymis luminal protein 57; epididymis secretory protein Li 27; HEL57; HEL-S-27; L M/N MN PI2; LEI; leukocyte elastase inhibitor; Leukocyte elastase inhibitor A; M/NEI; MNEI; Monocyte/neutrophil elastase inhibitor; ovalbumin; peptidase inhibitor 2; PI2; PI-2; protease inhibitor 2 (anti-elastase), monocyte/neutrophil derived; serine (or cysteine) peptidase inhibitor, clade B, member 1a; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 1; serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 1a; serine (or cysteine) proteinase inhibitor, clade B, member 1a; serine protease inhibitor EIA; serpin; Serpin B1; Serpin B1a; serpin family B member 1; serpin peptidase inhibitor, clade B (ovalbumin), member 1; Serpinb1; Serpinb1a |
| Símbolos de los genes | SERPINB1 |
| Afficher plus |
Nom du produit
En cliquant sur Soumettre, vous reconnaissez que vous pouvez être contacté par Fisher Scientific au sujet des informations que vous avez fournies dans ce formulaire. Nous ne partagerons pas vos informations à d'autres fins. Toutes les informations de contact fournies seront également conservées conformément à notre politique de confidentialité. Politique de confidentialité.
Vous avez repéré une opportunité d'amélioration ?
